vidarabine phosphate

Preferred Label : vidarabine phosphate;

MeSH definition : An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.;

MeSH synonym : phosphate, vidarabine; monophosphate, adenine arabinoside; 9-(5-o-phosphono-beta-d-arabinofuranosyl)-9h-purin-6-amine; ara-amp; monophosphate, vidarabine; arabinofuranosyladenine monophosphate; vidarabine monophosphate; adenine arabinoside monophosphate; ara amp; monophosphate, arabinofuranosyladenine;

CISMeF synonym : 9-(5-o-phosphono-.beta.-d-arabinofuranosyl)adenine;

MeSH CAS label : 9H-Purin-6-amine, 9-(5-O-phosphono-beta-D-arabinofuranosyl)-;

MeSH Related Number : 29984-33-6 (Vidarabine phosphate);

Registry Number MeSH : 29984-33-6;

MeSH annotation : a vidarabine ester antimetabolite; DF: note short X ref;

Codes EINECS : 249-990-8;

Is substance : O;

UNII : 106XV160TZ;

InChIKey : UDMBCSSLTHHNCD-UHTZMRCNSA-N;

Details

Origin ID

D001084;

UMLS CUI

C0003674;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- 9-(5-o-phosphono-.beta.-d-arabinofuranosyl)adenine [Substance BNPC]
Currated CISMeF NLP mapping
- Vidarabine Phosphate [NCIt concept]
Pharmacological action(s)
- antimetabolites [MeSH Descriptor]
- antiviral agents [MeSH Descriptor]
Record concept(s)
- vidarabine phosphate [MeSH concept]
Related MeSH Supplementary Concept(s)
- FLUDAP protocol [MeSH Supplementary Concept]
- ara-ATP [MeSH Supplementary Concept]
- cyclic 9 beta-D-arabinosyladenine 3',5'-monophosphate [MeSH Supplementary Concept]
- fludarabine phosphate [MeSH Supplementary Concept]
- lactosaminated polylysine-adenine arabinoside monophosphate [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 9-(5-o-phosphono-.beta.-d-arabinofuranosyl)adenine [Substance BNPC]
- Vidarabine Phosphate [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients